Advertisement

Topics

Nonproliferative retinopathy - Biotech, Pharma and Life Science Channel

14:44 EST 3rd December 2016 | BioPortfolio

PubMed Articles [340 Associated PubMed Articles listed on BioPortfolio]

Express of concern on 'Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy'.

The Relationship between Nonalcoholic Fatty Liver Disease and Retinopathy in NHANES III.

Nonalcoholic fatty liver disease (NAFLD), an emerging multisystem disease, has the similar pathogenesis with diabetes and is prevalent in diabetes. This study investigated whether NAFLD is associated ...

Inner Retinal Oxygen Delivery, Metabolism, and Extraction Fraction in Ins2Akita Diabetic Mice.

Retinal nonperfusion and hypoxia are important factors in human diabetic retinopathy, and these presumably inhibit energy production and lead to cell death. The purpose of this study was to elucidate ...

Integrated Cardio-Respiratory Control: Insight in Diabetes.

Autonomic dysfunction is a frequent and relevant complication of diabetes mellitus, as it is associated with increased morbidity and mortality. In addition, it is today considered as predictive of the...

GEMCITABINE-INDUCED RETINOPATHY.

To report a case of Purtscher-like retinopathy associated with gemcitabine.

Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy.

The aim of this study was to evaluate the relationship between the intravitreal vascular endothelial growth factor (VEGF) level and prognosis of proliferative diabetic retinopathy (PDR).

Diabetes and diabetic retinopathy in people aged 50 years and older in Hungary.

The purpose of this study was to estimate the prevalence of diabetes mellitus (DM) and diabetic retinopathy (DR) in the population aged 50 years and older in Hungary, and to assess the coverage of d...

A lower dose of intravitreal bevacizumab effectively treats retinopathy of prematurity.

To determine whether a low dose (0.25 mg/0.01 mL) of intravitreal bevacizumab is effective in the treatment of type 1 retinopathy of prematurity (ROP).

Anti-angiogenic Therapy for Retinal Disease.

Recent breakthroughs in our understanding of the molecular pathophysiology of retinal vascular disease have allowed us to specifically target pathological angiogenesis while minimizing damage to the n...

Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy.

Pathological angiogenesis is the hallmark of diseases such as cancer and retinopathies. Although tissue hypoxia and inflammation are recognized as central drivers of vessel growth, relatively little i...

News Articles [163 Associated News Articles listed on BioPortfolio]

Global Diabetic Eye Disease Devices Market 20162020 Prices from USD $2500

About Diabetic Eye Disease DevicesDiabetes eye diseases consist of a group of eyerelated conditions that affect individuals with diabetes. The conditions include diabetic macular edema DME, diabetic r...

Global Human Insulin Market 20152019 Prices from USD $2500

About diabetesInsulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amin...

Perceived Barriers to Diabetic Retinopathy Screening

Why aren't many low income and minority diabetic patients being screened for diabetic retinopathy? This study found a striking divergence of opinion between patients and providers. Preventing Chroni...

Google AI Matches Diabetic Retinopathy Screens

Using the latest tools in machine learning, scientists at Google have taught a computer algorithm to screen for diabetic retinopathy with sensitivity and specificity rivalling that of ophthalmologists...

Study: Deep learning algorithms show high accuracy for spotting diabetes retinopathy

The study underscores both the interest in developing machine learning tools for clinical decision support and making early detection of diabetic retinopathy easier.

Google’s training AI to catch diabetic blindness before it’s too late

  SOURCE November 2016 The disease is treatable but only if it is discovered in time. Diabetes is no joke, regardless of what Wilford Brimley memes you’ve seen. The disease’s associated f...

Deep-Learning Algorithm Shows Promise in Diabetic Eyes (CME/CE)

(MedPage Today) -- Automated software accurately identifies referable retinopathy

Early eye exams critical to detecting diabetic retinopathy

The NIH says early detection and treatment can reduce the risk of blindness from diseases such as diabetic retinopathy by 95%. In many instances, a comprehensive, dilated eye exam could detect the dis...

Study examines use of deep machine learning for detection of diabetic retinopathy

In an evaluation of retinal photographs from adults with diabetes, an algorithm based on deep machine learning had high sensitivity and specificity for detecting referable diabetic retinopathy, accord...

Artificial I ntelligence Looks Into Diabetic Retinopathy Screening

Diabetic retinopathy is a leading cause of vision loss in the United States and globally, particularly among working-aged individuals. Diabetic retinopathy meets all the criteria for screening: first,...

Events [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye di...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to de...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen def...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for...

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the ...

Clinical Trials [240 Associated Clinical Trials listed on BioPortfolio]

Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH

This is a phase I/II open label, randomized, interventional clinical trial. Study eyes will receive one preoperative intravitreal aflibercept injection (IAI) 7 days prior to vitrectomy and...

A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy

Diabetes affects 29.1 million people or 9.3% of the population of the United States. Results of a study by the Eye Diseases Prevalence Research Group reveal that 40% of diabetes patients h...

a Population Based Study on Metabolic Syndrome Complications, and Mortality

Metabolic syndrome (MetS) is recognized as clustering of a number of components including hypertension, hypertriglyceridemia, low serum high-density lipoprotein cholesterol (HDL-C), impair...

Early Laser Treatment for Diabetic Eye Disease in China : A Pilot Randomized Trial

To compare immediate laser pan-retinal photocoagulation (PRP) treatment of severe or very severe non proliferative diabetic retinopathy (NPDR) stage versus deferral of treatment until the ...

Automated Diagnostic Test for Diabetic Retinopathy in Brazilian Mass Screening

In Brazil 10% of the adult population has diabetes. Of these, 39.0% are undiagnosed, at risk for developing complications such as diabetic retinopathy (DR). Due to the increasing prevalenc...

A Prospective Observational Study Conducted in France to Describe Routine Clinical Practice for Treatment naïve or Previously Treated Patients With Diabetic Macular Edema (DME) Who Are Starting Intravitreal Aflibercept

The main objectives of this observational study are to describe effectiveness, monitoring and treatment patterns of patients with diabetic macular edema either treatment naïve patients or...

Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema

Multicenter randomized trials have demonstrated the safety and efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents for the treatment of diabetic macular ede...

Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study

Neovascular glaucoma is a potentially blinding condition characterized by the growth of newsless at the anterior part of the eye. This growth is driven by the overexpression of a protein c...

Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy

Panretinal photocoagulation (PRP) has been the standard treatment for Proliferative diabetic retinopathy (PDR) since the Diabetic Retinopathy Study demonstrated its benefit nearly 40 years...

Analyzing Retinal Microanatomy in ROP

Retinopathy of prematurity (ROP) is a disorder of development of the neural retina and its vasculature that may impact vision in vulnerable preterm neonates for a lifetime. This study util...

Videos

None available.

Medical and Biotech [MESH] Definitions

A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Degenerative changes to the RETINA due to HYPERTENSION.

A drug used to reduce hemorrhage in diabetic retinopathy.

Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Quick Search
Advertisement
 
review and buy Nonproliferative retinopathy market research data and corporate reports here

Channels Quicklinks